AcquisitionOther
Anebulo Pharmaceuticals, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Anebulo Pharmaceuticals, Inc. -> target · $0.99
Having secured such meaningful financing without having to issue stock at a discount to the market or include warrant coverage is indicative of the confidence these highly respected institutional investors have in the company's future," commented Richie Cunnin
Open source record (SEC) ↗